Dave is a Managing Partner in Sverica’s Boston office. Dave sits on the Board of Hirebotics, InflexionPoint, Clarest, First Fertility, Gener8 and Med First. Dave is a former Director of Resonetics, which was recapitalized first with GTCR then again with Carlyle; WHUSA, which was sold to Unified Women’s Healthcare; Dexmet, which was sold to PPG (NYSE: PPG); RestorixHealth, which was sold to Leonard Green & Partners; the Bartech Group, which was sold to Impellam Group PLC (LON: IPEL); MC Sign, which was sold to Caltius Equity Partners; and Center Rock, which was sole to Argonaut Private Equity.
Prior to joining Sverica, Dave served as a senior manager at The Parthenon Group, a strategy consulting firm, where he provided advisory services to private equity, mid-market and Fortune 1000 clients. Prior to joining Parthenon, Dave worked for Bain & Company as a consultant. Between Bain and Parthenon, he conducted a business turnaround as President of a manufacturing company in the custom wood products industry.
Dave graduated with distinction from the U.S. Naval Academy with a BS in Mechanical Engineering after which he served as a pilot and squadron maintenance division officer in the Navy. Dave transitioned from the Navy by attending the Amos Tuck School at Dartmouth College where he earned his MBA with distinction and was an Amos Tuck Scholar.